Detalhe da pesquisa
1.
Simvastatin in Critically Ill Patients with Covid-19.
N Engl J Med
; 389(25): 2341-2354, 2023 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37888913
2.
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med
; 384(16): 1491-1502, 2021 04 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33631065
3.
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 777-789, 2021 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34351722
4.
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med
; 385(9): 790-802, 2021 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34351721
5.
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
JAMA
; 329(13): 1066-1077, 2023 04 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36942550
6.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
JAMA
; 329(1): 39-51, 2023 01 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36525245
7.
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
JAMA
; 329(14): 1183-1196, 2023 04 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37039790
8.
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
JAMA
; 330(18): 1745-1759, 2023 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37877585
9.
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA
; 327(13): 1247-1259, 2022 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35315874
10.
Propensity score weighting for causal subgroup analysis.
Stat Med
; 40(19): 4294-4309, 2021 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33982316
11.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
JAMA
; 326(6): 499-518, 2021 08 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34228774
12.
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
Int J Cancer
; 147(11): 3152-3159, 2020 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32391579
13.
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
JAMA
; 324(13): 1317-1329, 2020 10 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32876697
14.
Development and validation of machine learning models to identify high-risk surgical patients using automatically curated electronic health record data (Pythia): A retrospective, single-site study.
PLoS Med
; 15(11): e1002701, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30481172
15.
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
J Clin Oncol
; 42(1): 90-102, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37883734
16.
REMAP Periop: a randomised, embedded, multifactorial adaptive platform trial protocol for perioperative medicine to determine the optimal enhanced recovery pathway components in complex abdominal surgery patients within a US healthcare system.
BMJ Open
; 13(12): e078711, 2023 12 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38154902
17.
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis.
PLoS One
; 17(7): e0270668, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35802687
18.
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
Intensive Care Med
; 47(8): 867-886, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34251506
19.
Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.
JAMA Ophthalmol
; 139(10): 1143-1144, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34410311